395 related articles for article (PubMed ID: 17520319)
1. Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.
Parrott AC; Milani RM; Gouzoulis-Mayfrank E; Daumann J
J Neural Transm (Vienna); 2007; 114(8):959-68. PubMed ID: 17520319
[TBL] [Abstract][Full Text] [Related]
2. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
3. The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA.
Wetherell MA; Atherton K; Grainger J; Brosnan R; Scholey AB
Hum Psychopharmacol; 2012 Mar; 27(2):167-76. PubMed ID: 22389081
[TBL] [Abstract][Full Text] [Related]
4. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
Gouzoulis-Mayfrank E; Daumann J
J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
[TBL] [Abstract][Full Text] [Related]
5. Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects.
Parrott AC; Gouzoulis-Meyfrank E; Rodgers J; Solowij N
J Psychopharmacol; 2004 Dec; 18(4):572-5. PubMed ID: 15582925
[No Abstract] [Full Text] [Related]
6. Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.
Daumann J; Hensen G; Thimm B; Rezk M; Till B; Gouzoulis-Mayfrank E
Psychopharmacology (Berl); 2004 May; 173(3-4):398-404. PubMed ID: 14722704
[TBL] [Abstract][Full Text] [Related]
7. Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users.
Dafters RI; Hoshi R; Talbot AC
Psychopharmacology (Berl); 2004 May; 173(3-4):405-10. PubMed ID: 12955295
[TBL] [Abstract][Full Text] [Related]
8. MDMA, cortisol, and heightened stress in recreational ecstasy users.
Parrott AC; Montgomery C; Wetherell MA; Downey LA; Stough C; Scholey AB
Behav Pharmacol; 2014 Sep; 25(5-6):458-72. PubMed ID: 25014666
[TBL] [Abstract][Full Text] [Related]
9. Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls.
Quednow BB; Kühn KU; Hoenig K; Maier W; Wagner M
Neuropsychopharmacology; 2004 May; 29(5):982-90. PubMed ID: 14970829
[TBL] [Abstract][Full Text] [Related]
10. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
11. Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.
Parrott AC
Hum Psychopharmacol; 2013 Jul; 28(4):289-307. PubMed ID: 23881877
[TBL] [Abstract][Full Text] [Related]
12. Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans.
Pacifici R; Zuccaro P; Farré M; Poudevida S; Abanades S; Pichini S; Langohr K; Segura J; de la Torre R
Addiction; 2007 Jun; 102(6):931-6. PubMed ID: 17523988
[TBL] [Abstract][Full Text] [Related]
13. MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves.
Parrott AC
Neuropsychobiology; 2004; 50(4):329-35. PubMed ID: 15539865
[TBL] [Abstract][Full Text] [Related]
14. Modulation of 3,4-methylenedioxymethamphetamine effects by endocannabinoid system.
Valverde O; Rodríguez-Árias M
Curr Pharm Des; 2013; 19(40):7081-91. PubMed ID: 23574444
[TBL] [Abstract][Full Text] [Related]
15. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
Parrott A
Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
[No Abstract] [Full Text] [Related]
16. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
Bhattachary S; Powell JH
Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
[TBL] [Abstract][Full Text] [Related]
17. Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice.
Pontes H; Duarte JA; de Pinho PG; Soares ME; Fernandes E; Dinis-Oliveira RJ; Sousa C; Silva R; Carmo H; Casal S; Remião F; Carvalho F; Bastos ML
Toxicology; 2008 Oct; 252(1-3):64-71. PubMed ID: 18761051
[TBL] [Abstract][Full Text] [Related]
18. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
Quednow BB; Kühn KU; Hoppe C; Westheide J; Maier W; Daum I; Wagner M
Psychopharmacology (Berl); 2007 Jan; 189(4):517-30. PubMed ID: 16425060
[TBL] [Abstract][Full Text] [Related]
19. MDMA and temperature: a review of the thermal effects of 'Ecstasy' in humans.
Parrott AC
Drug Alcohol Depend; 2012 Feb; 121(1-2):1-9. PubMed ID: 21924843
[TBL] [Abstract][Full Text] [Related]
20. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
